NIBRX-4412: Malignant Mixed Mesodermal (Mullerian) Tumor

Dana-Farber Cancer Institute


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NU/NU Crl:NU(Ncr)-Foxn1nu)
subcutaneous subcutaneous patient material/ direct inject Not Specified 0
Model Quality Control
Technique Description Passage
not collected not collected
Publications
Title High-throughput Screening Using Patient-derived Tumor Xenografts To Predict Clinical Trial Drug Response.
Authors Gao H, Korn JM, Ferretti S ... Sellers WR.
Publication year 2015
Journal High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Patient
Sex female
Ethnicity not collected
Derived Model NIBRX-4412
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 62
Diagnosis Malignant Mixed Mesodermal (Mullerian) Tumor
Type not specified
PDX Mouse NIBRX-4412
Collection Site not specified
Grade ( Classification: )
Stage ( Classification: )

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: